Solactive Future Pharmaceutical Europe Index
The Solactive Future Pharmaceutical Europe Index tracks the performance of the 15 largest European pharmaceutical companies by market capitalization, weighted according to their “Innovation Value”, thereby allocating more weight to companies investing a higher percentage of their total assets in research and development.
Master Data
| ISIN: | DE000SLA5EB2 |
| Bloomberg Ticker: | SOLFUPHA Index |
| WKN: | SLA5EB |
Current Quotes
| Last quote (23 Jan 2026): | 838.16 |
| Day range: | 838.16 / 838.16 |
| Change abs./rel.: | 0.00 / 0.00% |
| Year range: | 544.13 / 849.61 |
| Name | Number of shares |
|---|---|
| MERCK KGAA | 0.164374 |
| HALEON PLC | 4.208757 |
| UCB SA | 0.348672 |
| GENMAB A/S | 0.457756 |
| NOVARTIS AG | 0.322145 |
| NOVO NORDISK A/S | 0.738589 |
| SANOFI SA | 0.451737 |
| GALDERMA GROUP AG | 0.118127 |
| ROCHE HOLDING AG | 0.36428 |
| IPSEN SA | 0.594982 |
| GSK PLC | 2.122687 |
| SANDOZ GROUP AG | 0.340632 |
| BAYER AG | 0.624132 |
| RECORDATI SPA | 0.663004 |
| ASTRAZENECA PLC | 0.634007 |